用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
MERRIMACK PHARMACEUTICALS INC [US](13)
SANOFI SA [FR](4)
ZHANG BO [US](2)
MCDONAGH CHARLOTTE [US](2)
MOYO VICTOR [US](2)
ONSUM MATTHEW DAVID [US](1)
SEVECKA MARK [US](1)
WAINSZELBAUM MARISA [US](1)
HUHALOV ALEXANDRA [US](1)
GARCIA GABRIELA [US](1)
专利信息
Translation Company
查询条件
展开筛选条件
[专利权人] 包含 'MERRIMACK PHARMACEUTICALS INC [US]'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
尾页
共
13
条记录, 当前第1/2页。
公开号
公开日
申请号
申请日
1.
US2014079703A1
2014/3/20
US201314015776
2013/8/30
专利标题
:COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
Disclosed are methods and compositions for inhibiting the growth of a tumor (e.g., a malignant tumor) in a subject. In particular, combination therapies for treating a tumor in a subject by co-administering an agent selected from i) an effective amount of an anti-estrogen agent
2.
WO2014036520A1
2014/3/6
WO2013US57714
2013/8/30
专利标题
:COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
Disclosed are methods and compositions for inhibiting the growth of a tumor (e.g., a malignant 5 tumor) in a subject. In particular, combination therapies for treating a tumor in a subject by coadministering an agent selected from i) an effective amount of an anti-estrogen agent
3.
WO2013188586A1
2013/12/19
WO2013US45495
2013/6/12
专利标题
:METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
4.
WO2013138371A1
2013/9/19
WO2013US30585
2013/3/12
专利标题
:METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING AN ANTI-ERBB3 ANTIBODY
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
Provided are methods for treating pancreatic cancer in a patient by co-administering combinations of an anti-ErbB3 antibody and one or more additional therapeutic agents. Further disclosed are the combinations of therapies which include: the an(i-ErbB3 antibody is coadministered with irinotecan, the anti-ErbB3 antibody is co-administered with paclitaxel (e.g., nab-paclitaxel), and the anti-ErbB3 antibody is coadministered with erlotinib and gemcitabine.
5.
TW201317002A
2013/5/1
TW20120123370
2012/6/29
专利标题
:Dosage and administration of anti-ErbB3 antibodies in combination with paclitaxel for treatment of gynecological cancers
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
SANOFI SA [FR]
;
Provided are methods and compositions for clinical treatment of advanced gynecological cancers using anti-ErbB3 antibodies combined with paclitaxel.
6.
TW201315481A
2013/4/16
TW20120122338
2012/6/22
专利标题
:Dosage and administration of anti-ErbB3 antibodies in combination with paclitaxel
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
SANOFI SA [FR]
;
Provided are methods and compositions for clinical treatment of breast cancer using anti-ErbB3 antibodies combined with paclitaxel.
7.
WO2013023043A2
2013/2/14
WO2012US50124
2012/8/9
专利标题
:TREATMENT OF ADVANCED SOLID TUMORS USING COMBINATION OF ANTI-ERBB3 IMMUNOTHERAPY AND SELECTED CHEMOTHERAPY
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
SANOFI SA [FR]
;
MOYO VICTOR [US]
;
PEARLBERG JOSEPH [US]
;
TABAH-FISCH ISABELLE [FR]
;
Provided are methods and compositions for clinical treatment of solid tumors (e.g., advanced solid tumors) using anti-ErbB3 antibodies combined with a second agent selected from the group consisting of gemcitabine, carboplatin, pemetrexed, and cabazitaxel. Also provided are methods and compositions for clinical treatment of solid tumors using anti-ErbB3 antibodies combined with cetuximab and irinotecan.
8.
TW201302792A
2013/1/16
TW20120121448
2012/6/15
专利标题
:Dosage and administration of anti-ErbB3 antibodies in combination with tyrosine kinase inhibitors
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
SANOFI SA [FR]
;
Provided are methods and compositions for clinical treatment of NSCLC using anti-ErbB3 antibodies combined with use of TKIs such as erlotinib or gefitinib.
9.
CA2833554A1
2012/11/15
CA20122833554
2012/5/4
专利标题
:METHODS FOR PREVENTING TOXIC DRUG-DRUG INTERACTIONS IN COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
Methods are disclosed for preventing toxic drug-drug interactions during combination cancer therapy with a drug that is an anti-ErbB3 agent, such as an anti-ErbB3 antibody, together with a drug that is a tyrosine kinase inhibitor and/or a drug that binds to alpha- 1 acid glycoprotein (e.g., erlotinib). Health care practitioners obtaining any one of the drugs are warned that when co-administering the drug that is an anti-ErbB3 agent with either or both of a drug that is a tyrosine kinase inhibito...
10.
CA2828043A1
2012/9/20
CA20122828043
2012/3/15
专利标题
:OVERCOMING RESISTANCE TO ERBB PATHWAY INHIBITORS
专利权人
:
MERRIMACK PHARMACEUTICALS INC [US]
;
Provided are methods for overcoming resistance to an ErbB pathway inhibitor, such as an EGFR inhibitor or a HER2 inhibitor. The resistance may be acquired resistance to an EGFR inhibitor, such as acquired resistance to gefitinib. In the methods provided, a subject exhibiting resistance to an ErbB pathway inhibitor is selected and both an ErbB 3 inhibitor and a second ErbB pathway inhibitor are administered to the subject, such as an EGFR inhibitor or a HER2 inhibitor. Also provided are methods f...
首页
1
2
尾页
共
13
条记录, 当前第1/2页。
当前查询条件: [专利权人] 包含 'MERRIMACK PHARMACEUTICALS INC [US]'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文